Dr. Byrareddy's Laboratory


Currently recruiting graduate students.
Please contact if you are interested.


Keywords
Collaborators
Funding
Techniques used in the laboratory
Personnel
Return to Dr. Byrareddy's home page
Dr. Byrareddy's biographical information
Lab Phone: 402-559-3028


Keywords

HIV/SIV/SHIV, neuroAIDS, transmission, drugs of abuse, HIV cure, gut homing molecules, immunotherapy, mucositis, Zika virus, SARS-CoV-2, COVID-19, Monkeypox 2022

top of page


Collaborators

Aftab Ansari and Eric Hunter, (Emory University)
Francois Villinger (New Iberia Research Center, University of Louisiana, Lafayette)
Richard Cummings (Harvard University)
James Arthos and Claudia Cicala (NIH)
Nebraska Food for Health Center at the University of Nebraska
Shilpa Buch, Howard Fox, Courtney Fletcher and Howard E. Gendelman (UNMC)
Philipa Santangelo (Wallace H. Coulter Department of Biomedical 

Engineering at Georgia Tech, Atlanta)
Ranga Uday Kumar, Molecular Biology & Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research (https://www.jncasr.ac.in/faculty/udaykumar)
Mirko Paiardini, Emory University (http://vaccines.emory.edu/faculty-evc/primary-faculty/paiardini_mirko.html)
Mahesh Mohan, Tulane University (https://medicine.tulane.edu/departments/microbiology-immunology-tnprc/faculty/mahesh-mohan-dvm-ms-phd)


Funding

1R21 Supplemental award (Chand PI) “Effects of SARS-CoV-2 Proteins on Airway Mucous Response and Associated LncRNAs

Limiting HIV establishment and maintenance by preserving intestinal immunity
MPI: Byrareddy/Paiardini
Source: NIH/NIAID R01AI129745
In this project, we will explore the therapeutic potential of a combined interleukin (IL)-21 and anti-α4β7 Ab intervention to reduce gut damage and immune activation, improve antiviral responses, and limit the size of the reservoir in ART-treated, SIV-infected rhesus macaques.

The combinatorial effects of opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latency
MPI: Buch S/Byrareddy S/Fox H.
Source: R01DA041751-01
In this proposal, we plan to investigate the involvement of the combinatorial effects of opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogenesis and latency and  to test this hypothesis in a primate model.

Host-Directed Therapy to Augment anti-M tuberculosis in Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma
PI: Byrareddy S.
Source: Tulane University


Personnel

Arpan Acharaya, PhD
Instructor

 

Arpan_Acharya_2021_crop.jpg

Sam Johnson, PhD

Samuel_Johnson

Kabita Pandey
Graduate Research Assistant

pandey2019.jpg

Rajesh Rajaiah, PhD
Instructor

rajesh_rajaiah.jpg

Dr. Byrareddy's home page
Dr. Byrareddy's biographical information

top of page